My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2010
Clinical Practice Management
GAO Report Calls for Study of Medicare Coverage of Home Infusion Therapy

A recent report released by the Government Accountability Office (GAO) recommends that the federal government study the possibility of extending coverage for home infusion services to Medicare beneficiaries, a move IDSA has long supported.

The report compares current coverage policies of traditional Medicare plans and private health plans, such as Medicare Advantage Plans, for this therapy and concludes the Department of Health and Human Services should examine the issue further. “Given the long and positive experience health insurers reported having with home infusion therapy coverage, further study of potential costs, savings, and vulnerabilities for the Medicare program is warranted,” the report notes. To download the report, visit GAO’s website.

IDSA remains engaged in this issue and has endorsed legislation that would extend coverage to Medicare recipients, which the Society and other advocates believe would reduce hospital stays, decrease costs, be more convenient for patients, and make patients less likely to be exposed to hospital-acquired infections. For more information, please see IDSA’s website.  
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
ACIP Adjusts Seasonal Influenza Vaccination Recommendation for Children
Influenza and Intra-Abdominal Infections Guidelines Available as Pocketcards
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Physicians Narrowly Dodge 21 Percent Cuts in Medicare Payments
Medicare Internet Enrollment Deadline is July 6
GAO Report Calls for Study of Medicare Coverage of Home Infusion Therapy
Another Delay on FTC’s ‘Red Flag’ Rule on Identity Theft
Global ID
Preparing for the Future of Global HIV/AIDS Funding
Policy and Advocacy
IDSA Urges Action on Antibiotic Development at Congressional Hearing
AMA Endorses 10 x ’20 Initiative
Your Colleagues
Members on the Move
Welcome, New Members!
Education & Resources
Revised CPT Coding Resources Available
Top Stories
IDSA Annual Meeting Update
IDSA, FDA, and NIAID to Hold Antibacterial Resistance Research Workshop, July 26-27
Physicians Forced to Make Cutbacks as Medicare Eliminates Payment for Consultation Codes
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.